Cravath, Swaine & Moore LLP Logo
  • Practices
  • People
  • Careers
  • News & Insights
  • Practices
  • People
  • Careers
  • News & Insights
  • Our Story
  • The Cravath System
  • Diversity & Inclusion
  • Pro Bono
  • Alumni Journal
  • 200.Cravath

Cravath’s London Office Moves to 100 Cheapside

Read More

News & Insights

Financial Times Recognizes Cravath in Legal Practice and Social Responsibility Categories of 2022 North America Innovative Lawyers Report

December 09, 2022

On December 6, 2022, Cravath was recognized by the Financial Times in connection with its annual “North America Innovative Lawyers” report. In the “Practice of Law – Market Firsts” category, the Firm received “Standout” honors for its representation of Starz in a copyright infringement and breach of contract action against MGM Domestic Television. The Firm was also recognized among “Commended” honorees for its representation of Thermo Fisher in its $20.9 billion acquisition of PPD, Inc.

In the “Social Responsibility – Responsible Business” category, Cravath’s Incarcerated Survivors’ Initiative received “Standout” honors. The Incarcerated Survivors’ Initiative assists incarcerated survivors of domestic and/or sexual violence, including on matters related to resentencing, parole and civil rights violations, working in partnership with legal and social services organizations. The Financial Times noted that the Initiative, “a pro bono legal clinic,” has worked in “setting precedents in several cases since the establishment of New York’s Domestic Violence Survivors Justice Act.”

Related Practices & Industries

  • Corporate
  • Mergers and Acquisitions
  • Litigation
  • Appellate
  • Intellectual Property Litigation
  • General Commercial Disputes
  • Pro Bono
  • Media and Entertainment
  • Healthcare and Life Sciences

Related News & Insights

Deals & Cases

April 15, 2021

Thermo Fisher Scientific’s $20.9 Billion Acquisition of PPD, Inc.

On April 15, 2021, Thermo Fisher Scientific Inc. (“Thermo Fisher”), a leader in serving science, and PPD, Inc. (“PPD”), a leading provider of clinical research services to the pharma and biotech industry, announced that their boards of directors have approved a definitive agreement under which Thermo Fisher will acquire PPD for $47.50 per share for a total cash purchase price of $17.4 billion plus the assumption of approximately $3.5 billion of net debt. Cravath is representing Thermo Fisher in connection with the transaction.

Cravath Bicentennial

Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.

Explore

Cravath, Swaine & Moore LLP Logo
  • CONTACT US
  • OUR STORY
  • ALUMNI PORTAL
  • DISCLAIMERS & NOTICES

Attorney Advertising. ©2025 Cravath, Swaine & Moore LLP.